Literature DB >> 2055341

Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 (insulin-dependent) diabetes mellitus.

G L Warnock1, N M Kneteman, E Ryan, R E Seelis, A Rabinovitch, R V Rajotte.   

Abstract

Purified islets of Langerhans and a kidney were transplanted into a 36-year-old patient who suffered from renal failure secondary to a 25 year history of Type 1 (insulin-dependent) diabetes mellitus. The islet graft contained 243,000 fresh islets (mean islet diameter 150 microns) that were syngeneic with the kidney graft and 368000 cryopreserved islets that had been collected from four other donors. The total of 10,000 islets/kg body weight was infused into the liver via the umbilical vein. Immunosuppression was induced with antilymphocyte globulin and maintained with prednisone, cyclosporine and azathioprine. Serum C-peptide levels (ng/ml) during fasting and after standard mixed meal feeding (Sustacal) were less than 0.12 preoperatively. Postoperatively, insulin secretion was restored: fasting C-peptide rose during the first 4 weeks to levels of 4 to 5 and Sustacal elicited a further rise to 6 to 7. Transplant renal function was stable. Daily fasting glucose (mmol/l, mean +/- SD) was 5.6 +/- 1 and 5.3 +/- 0.6 during the first and second months respectively and post-Sustacal glucose was 5.7 +/- 0.8. Exogenous insulin therapy was progressively withdrawn and stopped during the ninth week. Thereafter, fasting glucose was 4.7 +/- 0.5, 24 h mean glucose was 6.6 +/- 0.5, and normoglycaemia was maintained after Sustacal. These data show that this mass of freshly isolated and cryopreserved islets from multiple donors provided sustained function (3 months) that reversed insulin-dependence in an immunosuppressed Type 1 diabetic patient treated with simultaneous islet-kidney transplantation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055341     DOI: 10.1007/bf00404026

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  9 in total

1.  Zinc-dithizone reaction of pancreatic islets.

Authors:  W F McNARY
Journal:  J Histochem Cytochem       Date:  1954-05       Impact factor: 2.479

2.  Insulin independence after islet transplantation into type I diabetic patient.

Authors:  D W Scharp; P E Lacy; J V Santiago; C S McCullough; L G Weide; L Falqui; P Marchetti; R L Gingerich; A S Jaffe; P E Cryer
Journal:  Diabetes       Date:  1990-04       Impact factor: 9.461

3.  Continued function of pancreatic islets after transplantation in type I diabetes.

Authors:  G L Warnock; N M Kneteman; E A Ryan; M G Evans; R E Seelis; P F Halloran; A Rabinovitch; R V Rajotte
Journal:  Lancet       Date:  1989-09-02       Impact factor: 79.321

4.  Normoglycemia after implantation of purified islet cells in dogs.

Authors:  G L Warnock; M S Cattral; R V Rajotte
Journal:  Can J Surg       Date:  1988-11       Impact factor: 2.089

5.  A method for isolation of islets of Langerhans from the human pancreas.

Authors:  D W Gray; P McShane; A Grant; P J Morris
Journal:  Diabetes       Date:  1984-11       Impact factor: 9.461

6.  A long-term functioning human pancreatic islet allotransplant.

Authors:  F Largiadèr; E Kolb; U Binswanger
Journal:  Transplantation       Date:  1980       Impact factor: 4.939

7.  Blood flow measurements in autotransplanted pancreatic islets of the rat. Impairment of the blood perfusion of the graft during hyperglycemia.

Authors:  S Sandler; L Jansson
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

8.  Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients.

Authors:  P Diem; M Abid; J B Redmon; D E Sutherland; R P Robertson
Journal:  Diabetes       Date:  1990-05       Impact factor: 9.461

9.  Studies of the isolation and viability of human islets of Langerhans.

Authors:  G L Warnock; D Ellis; R V Rajotte; I Dawidson; S Baekkeskov; J Egebjerg
Journal:  Transplantation       Date:  1988-05       Impact factor: 4.939

  9 in total
  47 in total

1.  Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.

Authors:  N S Kenyon; M Chatzipetrou; M Masetti; A Ranuncoli; M Oliveira; J L Wagner; A D Kirk; D M Harlan; L C Burkly; C Ricordi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Intrahepatic human islet transplantation at the University of Pittsburgh: results in 25 consecutive cases.

Authors:  P B Carroll; C Ricordi; H R Rilo; P Fontes; R Khan; A G Tzakis; R Shapiro; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

3.  Glucose homeostasis is regulated by donor islets in xenografts.

Authors:  P B Carroll; Y Zeng; R Alejandro; T E Starzl; C Ricordi
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

4.  Effect of donor islet mass on metabolic normalization in streptozotocin-diabetic rats.

Authors:  B Keymeulen; H Teng; M Vetri; F Gorus; P In't Veld; D G Pipeleers
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

Review 5.  Islet transplantation: alternative sites.

Authors:  Amer Rajab
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

6.  25 YEARS OF THE RICORDI AUTOMATED METHOD FOR ISLET ISOLATION.

Authors:  Lorenzo Piemonti; Antonello Pileggi
Journal:  CellR4 Repair Replace Regen Reprogram       Date:  2013

7.  Maintenance of stimulus-secretion coupling and single beta-cell function in cryopreserved-thawed human islets of Langerhans.

Authors:  Stanley Misler; Adam Dickey; David W Barnett
Journal:  Pflugers Arch       Date:  2005-06-30       Impact factor: 3.657

8.  Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras.

Authors:  Y Zeng; S T Ildstad; S M Wren; H L Rilo; D R Bereiter; P B Carroll; A G Tzakis; T E Starzl; C Ricordi
Journal:  Transplant Proc       Date:  1992-06       Impact factor: 1.066

9.  Long-term survival of islet allografts in diabetic rats treated with FK 506.

Authors:  W J Tze; J Tai; S S Cheung; N Murase; C Ricordi; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

10.  Human islet allotransplantation under FK 506.

Authors:  C Ricordi; A Tzakis; P Carroll; Y Zeng; H L Rilo; R Alejandro; R Shapiro; J J Fung; D H Mintz; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.